We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Breakthrough Finding on Hibernation

By Biotechdaily staff writers
Posted on 28 Apr 2005
For the first time, scientists have induced a state of reversible metabolic hibernation in mice, an achievement they say may lead to new ways to treat cancer and prevent injury or death from insufficient blood supply to organs and tissues.

In this first demonstration of "hibernation on demand,” the scientists were able to induce a state of clinical torpor in mice for up to six hours before restoring metabolic function and activity. More...
They did this by placing the mice in a chamber filled with normal room air laced with 80 parts per million of hydrogen sulfide, a chemical normally produced in humans and animals that is believed to help regulate body temperature and metabolic activity. Within minutes, the mice stopped moving and appeared to lose consciousness and their respiration dropped from the normal 120 breaths per minute to fewer than 10 breaths per minute, while their core temperature dropped from 37oC to as low as 11oC.

During a hibernation-like state, cellular activity slows to a near standstill, which dramatically reduces an organism's need for oxygen. If this kind of temporary metabolic inactivity could be replicated in humans, it might help buy time for critically ill patients on organ-transplant lists and in operating rooms and emergency departments.

"Manipulating this metabolic mechanism for clinical benefit potentially could revolutionize treatment for a host of human ills related to ischemia or damage to living tissue from lack of oxygen,” explained lead investigator Mark Roth, Ph.D., of Fred Hutchinson Cancer Research Center (Seattle, WA, USA), whose findings were published in the April 22, 2005, issue of Science.

Dozens of documented cases exist of people surviving prolonged hibernation-like states with no lingering physical or neurologic damage. Even people with no heartbeat and no respiration and with a drastic drop in body temperature for over an hour have later been resuscitated and have made good recovery.

Dr. Roth hypothesizes that temporarily eliminating oxygen dependence in health cells could make them a less-vulnerable target for radiation and chemotherapy and thereby spare normal tissue during high-dose cancer therapy. "Right now in most forms of cancer treatment, we're killing off the normal cells long before we're killing off the tumor cells. By inducing metabolic hibernation in healthy tissue, we'd at least level the playing field.”

In addition to mice, Dr. Roth and his colleagues have also demonstrated the ability to metabolically arrest and then re-animate such organisms as yeast, worms, and the embryos of fruit flies and zebrafish.


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.